Medically Supervised Metabolic Support Consultations in Manasquan and Online
Vitalé provides peptide consultation services from its Manasquan, NJ clinic and may offer online consultations for eligible patients where permitted. Availability depends on your location, medical history, treatment goals, provider review, and applicable state requirements.
AOD-9604 is often described online as a “fat-loss peptide.” The more accurate description is this:
AOD-9604 is a fragment of human growth hormone studied for fat-metabolism signaling, without acting like full growth hormone.
Some patients ask about AOD-9604 when:
- They feel stuck despite a consistent diet and training
- They want a non-stimulant approach
- They want to avoid appetite-suppressant side effects
- They want a medically supervised plan, not an internet protocol
At Vitalé, AOD-9604 is discussed through secure online medical consultations, available to patients across the United States. The focus is on what AOD-9604 can realistically do, what it cannot do, and whether safer or more effective alternatives may make more sense for you.
What AOD-9604 Is
AOD-9604 is described in the medical literature as the C-terminal fragment of human growth hormone (Tyr-hGH 177–191).
It was developed to target fat-metabolism activity associated with growth hormone without the same growth-promoting actions.
In human safety reviews, AOD-9604 showed:
- No effect on serum IGF-1 levels
- No negative effect on carbohydrate metabolism in testing (reported in contrast to full growth hormone)
That distinction is the core reason AOD-9604 attracts interest.
What AOD-9604 May Help With (Realistic Framing)
Let’s keep this direct.
Based on how it has been studied, AOD-9604 may be considered by some patients for:
- Supporting fat-metabolism pathways at a mechanism level (not guaranteed visible fat loss)
- A plan that aims to avoid IGF-1 elevation
- A non-stimulant option, discussed alongside lifestyle and medical weight-management tools
What it is not
- A guaranteed fat-loss treatment
- A replacement for GLP-1 medications
- A substitute for a nutrition strategy or resistance training
What the Research Says
The encouraging part
Human safety summaries report that AOD-9604 was generally well tolerated in reviewed trials, with:
- No IGF-1 elevation
- No serious adverse events were clearly attributed to AOD-9604 in those studies
The part most websites leave out
Efficacy for weight loss has been mixed.
Reviews describe:
- Early signals suggesting fat-metabolism activity
- Lack of meaningful effect in later studies when paired with intensive diet and exercise programs
Independent reporting also not